Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract

@article{Hiyama2009EffectivenessOP,
  title={Effectiveness of prokinetic agents against diseases external to the gastrointestinal tract},
  author={T. Hiyama and M. Yoshihara and Shinji Tanaka and K. Haruma and K. Chayama},
  journal={Journal of Gastroenterology and Hepatology},
  year={2009},
  volume={24}
}
Prokinetic agents are effective not only for disease of the gastrointestinal (GI) tract but also for those external to the GI tract such as the central nervous system, and the respiratory, urologic, and metabolic organs. This article reviews the effectiveness of prokinetic agents against diseases external to the GI tract. Studies were identified by computerized and manual searches of the available literature. A Medline search was performed (1975–July, 2008) using the following medical subject… Expand
The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis
TLDR
A possible neuroprotective role for trimebutine maleate is proposed by altering the dynamics of the gut-brain axis interaction, thus suggesting an additional effect of trimesters on Helicobacter pylori eradication regimens against these pathologies. Expand
Pulmonary manifestations of gastroesophageal reflux disease
TLDR
The literature is sparse on the relation between GERD and respiratory diseases such as interstitial lung diseases and bronchiolitis obliterans including its role in pathogenesis, mechanisms of lung injury, and whether treatment of GERD is effective in managing such illnesses. Expand
Could prokinetic agents protect long-term nasogastric tube-dependent patients from being hospitalized for pneumonia? A nationwide population-based case-crossover study
TLDR
Prokinetic agent use had no negative association with pneumonia admission among long-term nasogastric tube-dependent patients in Taiwan among patients with first-time hospitalizations for pneumonia. Expand
Hiccup: Mystery, Nature and Treatment
TLDR
Hiccup is likely to result from lesions involving the hiccup reflex arc, and drugs acting on reflex arc may be effective, while some other conventional measures may also be tried. Expand
Pathophysiology prevention and management of chronic neurogenic constipation in adults
TLDR
Neurogenic constipation occurs most commonly after spinal cord injury, in multiple sclerosis and in Parkinson`s disease, where patients are unable to defecate voluntarily due to the loss of the rectal fullness sensation and they depend on the spinal reflexes. Expand
Hiccups in palliative patients: a mini review
Submit Manuscript | http://medcraveonline.com are cerebrovascular accidents, mechanical injuries of central nervous system (tumours, inflammation or traumatism), vagus and phrenic nerve irritationExpand
Neurogenic bowel dysfunction in patients with spinal cord injury, myelomeningocele, multiple sclerosis and Parkinson's disease.
  • R. A. Awad
  • Medicine
  • World journal of gastroenterology
  • 2011
TLDR
This review covers the data related to the etiology, epidemiology, clinical expression, pathophysiology, genetic aspects, gastrointestinal motor dysfunction, visceral sensitivity, management, prevention and prognosis of neurogenic bowel dysfunction patients with these neurological diseases. Expand
ESPEN guidelines on nutrition in cancer patients.
TLDR
These evidence-based guidelines were developed to translate current best evidence and expert opinion into recommendations for multi-disciplinary teams responsible for identification, prevention, and treatment of reversible elements of malnutrition in adult cancer patients. Expand
Short-term hyperprolactinemia decreases allergic inflammatory response of the lungs.
TLDR
Data suggest that prolactin may play a role in the pathophysiology of asthma, and demonstrates a prospective beneficial side effect of domperidone for asthmatic patients. Expand
Short Report: Persistent Hiccups Following Stapedectomy
TLDR
A case of a 37 year-old man who de-veloped persistent hiccups after elective stapedectomy is reported, in which a pa-tient presented with this kind of symptoms with them persist-ing for a relatively long time and required a lot of attention from the medical and nursing staff. Expand
...
1
2
...

References

SHOWING 1-10 OF 163 REFERENCES
Gastrointestinal motility and prokinetics in the critically ill
TLDR
Upper gastrointestinal function in health together with abnormalities seen during critical illness are reviewed, and potential therapeutic options summarized, and Elevated concentrations of hormones such as cholecystokinin and peptide YY are potential mediators for these phenomena. Expand
Trimebutine: Mechanism of Action, Effects on Gastrointestinal Function and Clinical Results
TLDR
Clinically, trimebutine has proved to be effective in the treatment of both acute and chronic abdominal pain in patients with functional bowel disorders, especially irritable bowel syndrome, at doses ranging from 300 to 600 mg/day and it is also effective in children presenting with abdominal pain. Expand
Tegaserod for the treatment of irritable bowel syndrome and chronic constipation.
TLDR
Tegaserod did not significantly improve the patients' individual symptoms of abdominal pain and discomfort although bowel habit showed a statistically significant improvement with tegaserod 4 mg and there was a non-significant trend in this outcome in favour of tegasers 12 mg. Expand
The Use of Tegaserod in Critically ill Patients with Impaired Gastric Motility
TLDR
Tegaserod, a selective serotonin type 4 receptor partial agonist, was recently approved for treatment of women with irritable bowel syndrome was hypothesized that tegaserod may accelerate the return of gastric function in intensive care unit patients with gastroparesis. Expand
Domperidone: A Peripherally Acting Dopamine2-Receptor Antagonist
  • J. Barone
  • Medicine
  • The Annals of pharmacotherapy
  • 1999
TLDR
In controlled clinical trials, domperidone provided better relief of symptoms than placebo in patients with symptoms of diabetic gastroparesis and prevented the gastrointestinal and emetic adverse effects of antiparkinsonian drugs. Expand
Clinical implications of enteric and central D2 receptor blockade by antidopaminergic gastrointestinal prokinetics
TLDR
It has been suggested that the serotonergic (5‐HT4) component of some antidopaminergic prokinetics may enhance their therapeutic efficacy in gastrointestinal disorders, such as functional dyspepsia and diabetic gastroparesis. Expand
Domperidone: Review of Pharmacology and Clinical Applications in Gastroenterology
TLDR
The pharmacology, clinical application, and safety profile of domperidone are revisited to revisit the pharmacology and clinical application of this beneficial medication. Expand
Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
TLDR
Four to 6 weeks of a proton-pump inhibitor alone or in combination with a prokinetic agent successfully diagnoses and treats four of five patients with GERD-related cough. Expand
Strategy for treatment of nonerosive reflux disease in Asia.
The paper is to review the clinical and pathophysiologic differences between of nonerosive reflux disease (NERD) and reflux esophagitis (RE), and to propose a treatment strategy for NERD, especiallyExpand
The effect of metoclopramide treatment on diabetic cystoparesis.
TLDR
The effect on asymptomatic diabetic cystoparesis of metoclopramide given for the treatment of symptomatic diabetic gastroparesis was observed. Expand
...
1
2
3
4
5
...